Neuroendocrine Tumors: Challenges and Future Perspectives
- PMID: 35955968
- PMCID: PMC9369270
- DOI: 10.3390/jcm11154351
Neuroendocrine Tumors: Challenges and Future Perspectives
Abstract
The awareness and interest of the scientific community towards Neuroendocrine tumors (NETs) has progressively increased in the last few decades [...].
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Peptide Receptor Radionuclide Therapy and the Treatment of Gastroentero-pancreatic Neuroendocrine Tumors: Current Findings and Future Perspectives.Nucl Med Mol Imaging. 2018 Jun;52(3):190-199. doi: 10.1007/s13139-018-0517-x. Epub 2018 Mar 28. Nucl Med Mol Imaging. 2018. PMID: 29942397 Free PMC article. Review.
-
Neuroendocrine Tumors of the Gastrointestinal Tract: A Focused Review and Practical Approach for Gastroenterologists.GE Port J Gastroenterol. 2021 Sep;28(5):336-348. doi: 10.1159/000512089. Epub 2021 Jan 20. GE Port J Gastroenterol. 2021. PMID: 34604465 Free PMC article. Review.
-
Future perspectives on neuroendocrine tumors.Cancer Metastasis Rev. 2011 Mar;30 Suppl 1:35-40. doi: 10.1007/s10555-011-9294-z. Cancer Metastasis Rev. 2011. PMID: 21327890 Review.
-
Global burden of neuroendocrine tumors and changing incidence in Kentucky.Oncotarget. 2018 Apr 10;9(27):19245-19254. doi: 10.18632/oncotarget.24983. eCollection 2018 Apr 10. Oncotarget. 2018. PMID: 29721198 Free PMC article.
-
Pancreatic neuroendocrine tumors: Nosography, management and treatment.Int J Surg. 2016 Apr;28 Suppl 1:S156-62. doi: 10.1016/j.ijsu.2015.12.052. Epub 2015 Dec 18. Int J Surg. 2016. PMID: 26708853 Review.
Cited by
-
Standardized Uptake Values on SPECT/CT: A Promising Alternative Tool for Treatment Evaluation and Prognosis of Metastatic Neuroendocrine Tumours.Diagnostics (Basel). 2023 Jan 15;13(2):318. doi: 10.3390/diagnostics13020318. Diagnostics (Basel). 2023. PMID: 36673128 Free PMC article.
-
miRNA profile in pancreatic neuroendocrine tumors: Preliminary results.Sci Prog. 2025 Jan-Mar;108(1):368504251326864. doi: 10.1177/00368504251326864. Epub 2025 Mar 28. Sci Prog. 2025. PMID: 40152231 Free PMC article.
-
The radiologic spectrum of neuroendocrine tumors in emergent care.Rev Endocr Metab Disord. 2025 Apr;26(2):175-186. doi: 10.1007/s11154-024-09940-7. Epub 2025 Jan 2. Rev Endocr Metab Disord. 2025. PMID: 39745542 Review.
-
The Role of the Tumor Microenvironment in Gastroenteropancreatic Neuroendocrine Tumors.Int J Mol Sci. 2025 Jun 12;26(12):5635. doi: 10.3390/ijms26125635. Int J Mol Sci. 2025. PMID: 40565098 Free PMC article. Review.
References
-
- Yao J.C., Hassan M., Phan A., Dagohoy C., Leary C., Mares J.E., Abdalla E.K., Fleming J.B., Vauthey J.N., Rashid A., et al. One hundred years after ‘carcinoid’: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J. Clin. Oncol. 2008;26:3063–3072. doi: 10.1200/JCO.2007.15.4377. - DOI - PubMed
-
- Garcia-Carbonero R., Capdevila J., Crespo-Herrero G., Diaz-Perez J.A., Del Prado M.M., Orduña V.A., Sevilla-García I., Villabona-Artero C., Beguiristain-Gómez A., Llanos-Muñoz M., et al. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): Results from the National Cancer Registry of Spain (RGETNE) Ann. Oncol. 2010;21:1794–1803. doi: 10.1093/annonc/mdq022. - DOI - PubMed
-
- Oberg K., Couvelard A., Delle Fave G., Gross D., Grossman A., Jensen R.T., Pape U.F., Perren A., Rindi G., Ruszniewski P., et al. ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Biochemical Markers. Neuroendocrinology. 2017;105:201–211. doi: 10.1159/000472254. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources